AAAAAA
Results:
1-17
|
Results: 17
Authors:
Choi, P
Golts, N
Snyder, H
Chong, M
Petrucelli, L
Hardy, J
Sparkman, D
Cochran, E
Lee, JM
Wolozin, B
Citation: P. Choi et al., Co-association of parkin and alpha-synuclein, NEUROREPORT, 12(13), 2001, pp. 2839-2843
Authors:
Wolozin, B
Citation: B. Wolozin, A fluid connection: Cholesterol and A beta, P NAS US, 98(10), 2001, pp. 5371-5373
Authors:
Palacino, JJ
Murphy, MP
Murayama, O
Iwasaki, K
Fujiwara, M
Takashima, A
Golde, TE
Wolozin, B
Citation: Jj. Palacino et al., Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion, J BIOL CHEM, 276(42), 2001, pp. 38563-38569
Authors:
Wolozin, B
Siegel, G
Citation: B. Wolozin et G. Siegel, Report on statins and dementia disputed - In reply, ARCH NEUROL, 58(7), 2001, pp. 1167-1167
Authors:
Wolozin, B
Siegel, G
Citation: B. Wolozin et G. Siegel, Statins and dementia - In reply, ARCH NEUROL, 58(7), 2001, pp. 1170-1170
Authors:
Wolozin, B
Siegel, G
Citation: B. Wolozin et G. Siegel, Statin-Alzheimer disease association not yet proven - In reply, ARCH NEUROL, 58(6), 2001, pp. 1023-1023
Authors:
Wolozin, B
Siegel, G
Citation: B. Wolozin et G. Siegel, Statin therapy and the prevention of dementia - In reply, ARCH NEUROL, 58(6), 2001, pp. 1024-1024
Authors:
Choi, P
Ostrerova-Golts, N
Sparkman, D
Cochran, E
Lee, JM
Wolozin, B
Citation: P. Choi et al., Parkin is metabolized by the ubiquitin/proteosome system, NEUROREPORT, 11(12), 2000, pp. 2635-2638
Authors:
Ostrerova-Golts, N
Petrucelli, L
Hardy, J
Lee, JM
Farer, M
Wolozin, B
Citation: N. Ostrerova-golts et al., The A53T alpha-synuclein mutation increases iron-dependent aggregation andtoxicity, J NEUROSC, 20(16), 2000, pp. 6048-6054
Authors:
Palacino, JJ
Berechid, BE
Alexander, P
Eckman, C
Younkin, S
Nye, JS
Wolozin, B
Citation: Jj. Palacino et al., Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cells, J BIOL CHEM, 275(1), 2000, pp. 215-222
Authors:
Wolozin, B
Behl, C
Citation: B. Wolozin et C. Behl, Mechanisms of neurodegenerative disorders part 1: Protein aggregates, ARCH NEUROL, 57(6), 2000, pp. 793-796
Authors:
Wolozin, B
Behl, C
Citation: B. Wolozin et C. Behl, Mechanisms of neurodegenerative disorders part 2: Control of cell death, ARCH NEUROL, 57(6), 2000, pp. 801-804
Authors:
Wolozin, B
Kellman, W
Ruosseau, P
Celesia, GG
Siegel, G
Citation: B. Wolozin et al., Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, ARCH NEUROL, 57(10), 2000, pp. 1439-1443
Authors:
Yankner, B
Wolozin, B
Koo, E
Kosik, K
Weihl, C
Citation: B. Yankner et al., beta-catenin and PS1 - Alzheimer's Research Forum - Panel Discussion - 13(th) August 1999, ALZHEIM REP, 2(5), 1999, pp. 259-261
Authors:
Ostrerova, N
Petrucelli, L
Farrer, M
Mehta, N
Choi, P
Hardy, J
Wolozin, B
Citation: N. Ostrerova et al., alpha-Synuclein shares physical and functional homology with 14-3-3 proteins, J NEUROSC, 19(14), 1999, pp. 5782-5791
Authors:
Abrams, MT
Kaufmann, WE
Rousseau, F
Oostra, BA
Wolozin, B
Taylor, CV
Lishaa, N
Morel, ML
Hoogeveen, A
Reiss, AL
Citation: Mt. Abrams et al., FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome, AM J MED G, 82(1), 1999, pp. 25-30
Authors:
Sunderland, T
Wolozin, B
Galasko, D
Levy, J
Dukoff, R
Bahro, M
Lasser, R
Motter, R
Lehtimaki, T
Seubert, P
Citation: T. Sunderland et al., Longitudinal stability of CSF tau levels in Alzheimer patients, BIOL PSYCHI, 46(6), 1999, pp. 750-755
Risultati:
1-17
|